Zhejiang Wolwo Bio-pharmaceutical Co. LTD.   Report issue

For profit Phase 2 Phase 3
Founded: Huzhou China (2002)
Status: Left NME R&D (2022)

Organization Overview

First Clinical Trial
2011
NCT01471119
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Alternative names

Wolwo Pharma | Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd.

Active Ingredients

Drugs in Phase 3 Trials (1)

artemisia (1 trial)

Drugs in Phase 2 Trials (1)

house dust mite allergen (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Dermatitis (Phase 2)

Dermatitis, Atopic (Phase 2)

Eczema (Phase 2)

Rhinitis (Phase 3)

Rhinitis, Allergic (Phase 3)

Rhinitis, Allergic, Seasonal (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 2
  • # of Trial APIs: 2